Emcure Pharmaceuticals Ltd Quarterly Results

Gross Sales

2,269.82

2,100.54

2,116.25

1,962.63

2,001.98

Excise Duty

0

0

0

0

0

Net Sales

2,269.82

2,100.54

2,116.25

1,962.63

2,001.98

Other Operating Income

0

0

0

0

0

Other Income

3.12

3.7

4.45

-3.24

35.65

Total Income

2,272.95

2,104.23

2,120.7

1,959.39

2,037.64

Total Expenditure

1,794.34

1,687.26

1,724.22

1,600.89

1,621.11

PBIDT

478.6

416.97

396.48

358.5

416.53

Interest

32.54

26.76

39.03

31.78

46.22

PBDT

446.06

390.21

357.45

326.73

370.31

Depreciation

104.64

99.46

96.84

96.81

96.9

Minority Interest Before NP

0

0

0

0

0

Tax

93.02

86.02

91.55

58.93

79.8

Deferred Tax

-2.97

-10.05

-28.18

14.9

-7.94

Reported Profit After Tax

251.37

214.79

197.24

156.09

201.55

Minority Interest After NP

7.91

7.84

8.28

2.37

6.98

Net Profit after Minority Interest

243.46

206.95

188.96

153.72

194.57

Extra-ordinary Items

0

-2.46

-6.73

0

0

Adjusted Profit After Extra-ordinary item

243.46

209.41

195.69

153.72

194.57

EPS (Unit Curr.)

12.85

10.92

9.97

8.12

10.23

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

30

0

0

Equity

189.57

189.51

189.48

189.43

189.1

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

21.08

19.85

18.73

18.26

20.8

PBDTM(%)

19.65

18.57

16.89

16.64

18.49

PATM(%)

11.07

10.22

9.32

7.95

10.06